GeoVax Labs, Inc. — Director's Dealing 2021

Aug 11, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GeoVax Labs, Inc. (GOVX)
CIK: 0000832489
Period of Report: 2021-08-11

Reporting Person: DODD DAVID A (Director, President, CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-11	Stock Option (right to buy)	$2.79	A	273000	Acquired	2030-12-02	Common Stock (273000)	Direct

Footnotes

F1: This stock option was granted on December 2, 2020, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan. Such approval was obtained on August 11, 2021, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance.

F2: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.